4Dawson TM ,Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease [J]. Science,2003,2(5646) :819.
5Nobutaka A, Yoshio G. Valuation of a 1 - methyl - 4 - phenyl - 1,2, 3,6 -tetrahydropyridine (MPTP) -treated C57 black mouse model for parkinsonism [ J ]. Brain Res, 1990,515 : 57 - 63.
6Blum D, Torch S, Lambeng N, et al. Molecular pathways involved in the neurotoxicity of 6 -OHDA,dopamine and MPTP: contribution to the apoptotic theory in Parkinson' s disease [ J ]. Prog Neurobiol, 2001,65(2) :135 - 172.
7Moon Y, Lee KH, Park JH, et al. Mitoohondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q lo [ J ]. J Neurochem,2005,93 (5) : 1199 - 1208.
8Czemiezyniec A, Bustamante J, Lores - Arnaiz S. Improvement of mouse brain mitochondrial function after deprenyl - treatment [ J ]. Neuroscienee ,2007,144(2) :685 -693.
9Plun - Favreau H, Klupsch K, Molsol N, et al. The mltochondrial protease HtrA2 is regulated by Parkinson's disease -associated kinase PINK1 [J]. Nat Cell Bio1,2007,9( 11 ) :1227 - 1229.
